Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
TrivarX Limited ( (AU:TRI) ) just unveiled an announcement.
TrivarX Limited has issued 437,725,337 new fully paid ordinary shares at $0.008 per share as part of a placement previously announced in October and approved by shareholders in December. The company has confirmed that these shares were issued without a prospectus under the Corporations Act disclosure exemptions, while affirming its ongoing compliance with financial reporting and continuous disclosure obligations and stating that there is no withheld price-sensitive information, providing investors with reassurance about transparency and regulatory adherence around the capital raising.
More about TrivarX Limited
TrivarX Limited is an Australia-founded mental health technology company that develops objective measurement tools to assist with early detection and screening of mental health conditions. Listed on the ASX and trading on the OTCQB Venture Market, the company operates from offices in Perth and Minneapolis, targeting investors and stakeholders in both Australian and North American markets.
YTD Price Performance: 6.25%
Average Trading Volume: 3,115,487
Technical Sentiment Signal: Sell
Current Market Cap: A$12.17M
For an in-depth examination of TRI stock, go to TipRanks’ Overview page.